Stockscreener 앱 받기
30.01
0.66%
-0.20
시간 외 거래:
30.01
전일 마감가:
$30.21
열려 있는:
$30.39
하루 거래량:
21,608
Relative Volume:
0.89
시가총액:
$355.72M
수익:
$9.71M
순이익/손실:
$-29.96M
주가수익비율:
-11.16
EPS:
-2.69
순현금흐름:
$-14.79M
1주 성능:
-3.69%
1개월 성능:
+2.07%
6개월 성능:
+17.64%
1년 성능:
+87.91%
1일 변동 폭
$29.50
$31.08
1주일 범위
$29.09
$32.50
52주 변동 폭
$14.33
$33.78
Xoma Royalty Corp Stock (XOMA) Company Profile
명칭
Xoma Royalty Corp
전화
510-204-7239
주소
2200 POWELL STREET, EMERYVILLE, CA
XOMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| XOMA | 30.01 | 355.72M | 9.71M | -29.96M | -14.79M | -2.69 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-09-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-06-29 | 개시 | Aegis Capital | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-17 | 재개 | H.C. Wainwright | Buy |
| 2017-09-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2017-06-12 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-11 | 재확인 | Wedbush | Outperform |
| 2015-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-07-22 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 재개 | ROTH Capital | Buy |
| 2014-04-29 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-11 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2014-03-05 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-10-31 | 재확인 | MLV & Co | Buy |
| 2013-05-09 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-14 | 개시 | Cowen & Co | Outperform |
| 2011-03-31 | 재확인 | MLV Capital | Buy |
| 2011-03-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2011-01-06 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-01-04 | 재확인 | Wedbush | Outperform |
모두보기
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
Short Interest in XOMA Co. (NASDAQ:XOMA) Drops By 23.5% - Defense World
XOMA Co. (NASDAQ:XOMA) Sees Large Decrease in Short Interest - MarketBeat
Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 By Investing.com - Investing.com Australia
Xoma CEO Owen Hughes sells $655,335 in stock - Investing.com India
Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 - Investing.com
What Makes XOMA Royalty (XOMA) a New Buy Stock - Yahoo Finance
XOMA Royalty Reports Third Quarter 2024 Financial Results and Recent Activities - Defense World
What is HC Wainwright's Forecast for XOMA FY2025 Earnings? - MarketBeat
XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance
XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
XOMA Royalty’s Third Quarter 2024 Financial Insights - TipRanks
XOMA Royalty: Q3 Earnings Snapshot - CT Insider
XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - ForexTV.com
Xoma reports Q3 EPS ($1.59), consensus (44c) - TipRanks
XOMA Royalty Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News - StockTitan
XOMA stock soars to 52-week high, reaching $32 By Investing.com - Investing.com UK
XOMA stock soars to 52-week high, reaching $32 - Investing.com
XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World
XOMA Royalty Corporation's (NASDAQ:XOMA) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Simply Wall St
XOMA stock soars to 52-week high, reaching $30.7 By Investing.com - Investing.com South Africa
XOMA stock soars to 52-week high, reaching $30.7 - Investing.com India
XOMA’s (XOMA) Buy Rating Reaffirmed at HC Wainwright - Defense World
XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October - Defense World
Twist Bioscience enters into purchase agreement with XOMA Royalty - MSN
XOMA (NASDAQ:XOMA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
XOMA Royalty Corporation Acquires 50% of Twist's Existing Royalty and Milestone Economics for $15 Million - Marketscreener.com
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - The Manila Times
XOMA Royalty Significantly Expands its Royalty and - GlobeNewswire
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - The Bakersfield Californian
Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year - Yahoo Finance
Ellsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA) - MarketBeat
XOMA stock soars to 52-week high, reaching $30.49 - Investing.com
XOMA stock soars to 52-week high, reaching $30.49 By Investing.com - Investing.com South Africa
XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties (NASDAQ:XOMA) - Seeking Alpha
XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat
XOMA Co. (NASDAQ:XOMA) is Stonepine Capital Management LLC’s 6th Largest Position - Defense World
PIMCO Strategic Income Fund, XOMA Corporation, Another 2 Companies Have A High Estimated Dividend Yield - Via News Agency
Rhumbline Advisers Raises Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91 - Defense World
XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.91 - MarketBeat
XOMA Co. (NASDAQ:XOMAO) Announces $0.52 Quarterly Dividend - Defense World
XOMA shares hold as analyst reiterates Buy rating post-FDA nod - Investing.com
XOMA Royalty gains FDA-approved asset for NPC By Investing.com - Investing.com Canada
XOMA Royalty gains FDA-approved asset for NPC - Investing.com
XOMAOXOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock Latest Stock News & Market Updates - StockTitan
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. - GlobeNewswire
Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC - TipRanks
Xoma Royalty Corp (XOMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):